← Back to Search

Multilevel Connection Tool for Cancer Patients

N/A
Waitlist Available
Led By Janice Krieger, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up review 2 months after intervention
Awards & highlights

Study Summary

This trial tests a tool to help Black and Hispanic cancer patients & families get referrals to cancer treatment centers.

Who is the study for?
This trial is for Black and Hispanic adults aged 18 to 73 in Florida, who can read English or Spanish at an eighth-grade level, are willing to be re-contacted, and have email or text capabilities. It's aimed at those underrepresented in cancer clinical trials.Check my eligibility
What is being tested?
The study tests a tailored ALEX Research Portal with a virtual Community Health Educator against a stand-alone portal to help guide these populations through referrals to cancer clinical trials.See study design
What are the potential side effects?
Since this trial involves the use of informational portals rather than medical interventions, there are no direct physical side effects associated with participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 months of consent
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 months of consent for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients who self-refer to cancer clinical trials
Secondary outcome measures
Change in trust in Cancer Clinical Trials
Mediators of intervention effectiveness
Virtual Clinical Health Education (vCHE) preferences

Trial Design

2Treatment groups
Experimental Treatment
Group I: Stand-alone PortalExperimental Treatment1 Intervention
The standard of care condition will include a portal that provides patients with access to existing online cancer clinical trial resources in one location. This includes links to pages with basic information about cancer clinical trials, ongoing studies, enrollment opportunities for existing institutional research registries, and contact information for study coordinators.
Group II: Portal with Virtual Community Health Educator (vCHE)Experimental Treatment1 Intervention
The virtual community health educator condition will provide all information in standard of care with the addition of a virtual community health educator. Patients will have the opportunity to choose which virtual community health educator will provide digital navigation. The choices will include at least four English-speaking and four Spanish-speaking virtual community health educators representing different genders and racial/ethnic backgrounds.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,346 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,803 Total Patients Enrolled
Janice Krieger, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
2,968 Total Patients Enrolled

Media Library

ALEX Research Portal Clinical Trial Eligibility Overview. Trial Name: NCT05655494 — N/A
Cancer Research Study Groups: Stand-alone Portal, Portal with Virtual Community Health Educator (vCHE)
Cancer Clinical Trial 2023: ALEX Research Portal Highlights & Side Effects. Trial Name: NCT05655494 — N/A
ALEX Research Portal 2023 Treatment Timeline for Medical Study. Trial Name: NCT05655494 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric patients being incorporated into this research experiment?

"The eligibility requirements for this trial specify that all participants should be between 18 and 73 years of age."

Answered by AI

Are there currently openings available for patients to enrol in this experiment?

"According to the available documentation on clinicaltrials.gov, this trial is not presently recruiting new subjects; it was initially posted on January 1st 2023 and edited for the final time on December 15th 2022. However, there are currently 494 additional medical studies that require participants."

Answered by AI

Is my eligibility for this research project being considered?

"As part of this trial, 350 adults aged 18 to 73 with cancer are being recruited. Applicants must meet the following conditions: be literate in English or Spanish at a minimum eighth-grade level, originate from an historically underrepresented racial/ethnic background (e.g., Blacks or African Americans and/or Hispanics or Latinos), have access to email services or text messaging, consent for follow up contact and reside within Florida."

Answered by AI
~223 spots leftby Dec 2024